A1 Refereed original research article in a scientific journal

Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers




AuthorsLaura Heinonen, Birgitta Sandberg

PublisherSpringer

Publication year2008

Journal:Journal of Commercial Biotechnology

Volume14

First page 287

Last page298

Number of pages12

Web address https://link.springer.com/article/10.1057/jcb.2008.25




Last updated on 2024-26-11 at 15:55